Condition
Bilirubinemia
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT05692648Not ApplicableCompletedPrimary
Effect of Repositioning Frequency Neonates Receiving Phototherapy
NCT03259581Phase 1Completed
Safety of Transarterial Chemoembolization (TACE) in the Setting of an Elevated Bilirubin
NCT03684499Not ApplicableUnknownPrimary
Fluid in Neonatal Hyperbilirubinemia
Showing all 3 trials